Children and adults in the Netherlands with atypical hemolytic uremic syndrome (aHUS) experience differences in clinical presentation and outcomes despite carrying the same disease-linked genetic variant, according to a new study. Children with this variant presented with more profound blood cell abnormalities but milder kidney impairment than adult patients.
Two brothers carrying identical genetic variants associated with atypical hemolytic uremic syndrome (aHUS) and hereditary thrombotic thrombocytopenic purpura (TTP) developed different disease manifestations, as reported in a case series. TTP is a blood disorder, like aHUS, characterized by thrombotic microangiopathy (TMA), in which blood clots form in tiny…
Becoming educated and informed about aHUS is a good first step. Here you’ll find general information about the disease, including diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnist’s words of wisdom to help you along on your aHUS journey.
There is no cure for aHUS yet, but here you can find more information about current therapeutic approaches, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
